🇺🇸 Thymosin Alpha 1 in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 27

Most-reported reactions

1. Off Label Use — 8 reports (29.63%)
2. Fatigue — 3 reports (11.11%)
3. Abortion Spontaneous — 2 reports (7.41%)
4. Anaemia — 2 reports (7.41%)
5. Interstitial Lung Disease — 2 reports (7.41%)
6. Nausea — 2 reports (7.41%)
7. Pain — 2 reports (7.41%)
8. Peripheral Ischaemia — 2 reports (7.41%)
9. Pneumonia — 2 reports (7.41%)
10. Pregnancy — 2 reports (7.41%)

Source database →

Frequently asked questions

Is Thymosin Alpha 1 approved in United States?

Thymosin Alpha 1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Thymosin Alpha 1 in United States?

Xuanwu Hospital, Beijing is the originator. The local marketing authorisation holder may differ — check the official source linked above.